SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by LHM Inc.

LHM Inc. lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 106.5% during the second quarter, Holdings Channel reports. The fund owned 77,242 shares of the exchange traded fund’s stock after acquiring an additional 39,828 shares during the period. SPDR S&P Biotech ETF comprises 3.0% of LHM Inc.’s investment portfolio, making the stock its 4th largest position. LHM Inc.’s holdings in SPDR S&P Biotech ETF were worth $7,161,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $396,844,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after buying an additional 18,202 shares in the last quarter. Jane Street Group LLC increased its stake in shares of SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares during the period. Finally, Bessemer Group Inc. raised its holdings in SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after acquiring an additional 15,794 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.4 %

Shares of SPDR S&P Biotech ETF stock opened at $98.80 on Tuesday. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The company has a market capitalization of $7.53 billion, a P/E ratio of 11.47 and a beta of 1.11. The company has a 50 day moving average of $98.94 and a 200 day moving average of $93.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.